MedTrace Logo

Genosvid Diagnostic Test for Early Detection of COVID-19

NCT04558372 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1999

Last updated 2020-12-29

No results posted yet for this study

Summary

Electronic-nose had been used to diagnose other infectious lung diseases, such as tuberculosis. Universitas Gadjah Mada has developed an electronic-nose device which is easy-to-use, portable, and can be manufactured at a low price. Here the investigators test the electronic-nose to diagnose COVID-19 in Indonesia.

Conditions

Interventions

OTHER

exhaled breath sampling

The participants breath through non-rebreathing mask until the reservoir bag is full. The reservoir bag is connected to Hepa-filter at one side, and another side of Hepa-filter is connected to the electronic-nose (Genosvid) device.

OTHER

exhaled breath sampling

The participants breath through non-rebreathing mask until the reservoir bag is full. The reservoir bag is connected to Hepa-filter at one side, and another side of Hepa-filter is connected to the electronic-nose (Genosvid) device.

OTHER

exhaled breath sampling

The participants breath normally using a mask for 2 times then they are asked to inhale and exhale in a forced expiratory volume through an e-nose tube connected to the Hepa-filter at the inlet.

Sponsors & Collaborators

  • Gadjah Mada University

    lead OTHER

Principal Investigators

  • Dian K. Nurputra, MD(Paed), M.Sc, Ph.D · Faculty of Medicine, Public Health and Nursing Universitas Gadjah Mada

  • Kuwat Triyana, Prof, Dr.Eng, MSi. · Faculty of Mathematics and Natural Sciences Universitas Gadjah Mada

Study Design

Allocation
NON_RANDOMIZED
Purpose
DIAGNOSTIC
Masking
TRIPLE
Model
SINGLE_GROUP

Eligibility

Min Age
4 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-04-01
Primary Completion
2020-12-12
Completion
2020-12-12

Countries

  • Indonesia

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04558372 on ClinicalTrials.gov